The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 677.50
Bid: 677.00
Ask: 678.00
Change: -6.00 (-0.88%)
Spread: 1.00 (0.148%)
Open: 679.00
High: 684.00
Low: 675.00
Prev. Close: 683.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tate & Lyle New Chief Executive

19 May 2009 07:00

null

Tate & Lyle PLC (the "Company") announces that Javed Ahmed will join the Company as its new Chief Executive by 15 November 2009. Iain Ferguson, currently Chief Executive of Tate & Lyle, will continue in that role until Mr Ahmed's arrival and ensure an orderly handover.

Mr Ahmed is currently Executive Vice President, Europe for Reckitt Benckiser plc ("Reckitt"). He is a member of the Executive Committee of Reckitt having held a number of senior leadership roles within the group over the last 17 years in both Europe and North America.

Sir David Lees, Chairman of Tate & Lyle, said "Following our earlier announcement that Sir Peter Gershon will succeed me as Chairman by the end of the year, Peter and I are delighted that we are able to announce the succession arrangements for Iain Ferguson. We are most grateful to Iain for leading the transformation of the Group with such great skill and energy over the past six years. His contribution has been very significant and will continue as he leads the team in the next few months until Javed Ahmed joins us. We are confident that, in Javed, we have found a worthy successor to Iain to lead Tate & Lyle in the next phase of its development."

Sir Peter Gershon said "I congratulate Javed Ahmed on this exciting new opportunity and very much look forward to working with him in the years to come as we build on the strong foundations Iain and Sir David have established at Tate & Lyle."

Javed Ahmed said "I am delighted to have been offered the opportunity to lead Tate & Lyle, and look forward to working with the Board and the management team to drive the business forward."

END

For more information contact Tate & Lyle PLC:

MediaRowan Adams, Director of Corporate AffairsTel: 020 7626 6525 or Mobile: 07713 067542

William Baldwin-Charles, Head of Media RelationsTel: 020 7626 6525 or Mobile: 07810 151425

Investor RelationsChris McLeish Director of Investor RelationsTel: 020 7626 6525 or Mobile: 07919 102730

Tim Lodge, Group Finance DirectorTel: 020 7626 6525 or Mobile: 07798 837317

Notes to Editor

1. Biographical details of Javed Ahmed and Sir Peter Gershon are given below.

2. Iain Ferguson joined the Board of Tate & Lyle as Chief Executive on 1 May 2003.

3. Tate & Lyle will announce its preliminary results for the year ended 31 March 2009 on Thursday 28 May 2009.

Javed Ahmed

Javed Ahmed, aged 49, started his career with Procter & Gamble before spending five years with Bain & Co, working in both London and Boston.

In 1992, he joined Benckiser as General Manager, Canada, moving to the UK to run their UK and Irish operations in 1995. In 1999 his responsibilities, now within Reckitt Benckiser plc, were extended to Senior Vice President, Northern Europe.

In 2001, he assumed the role of President, North America and two years later was promoted to Executive Vice President, North America, Australia and New Zealand. In 2008, he was again promoted to Executive Vice President, Europe.

He has been a member of the Reckitt Benckiser Executive Committee since 2003.

Mr Ahmed graduated magna cum laude, phi beta kappa from Williams College (Massachusetts) in 1982 and obtained an MBA from the Stanford Graduate School of Business in 1984.

Sir Peter Gershon, CBE, FREng

Sir Peter, aged 62, has been Non-Executive Chairman of Premier Farnell plc since 1 March 2005. He also holds the position of Chairman at each of General Healthcare Group Ltd and Vertex Data Science Limited. He is a member of the Advisory Board of the UK Defence Academy and a member of the Council of Imperial College.

From 2000 until 2004, Sir Peter was chief executive officer of the Office of Government Commerce, where he led a major overhaul of government procurement practice and an efficiency review of the UK public sector.

From 1999 to 2000, Sir Peter was chief operating officer and a member of the Board of BAe Systems. Prior to that, he was managing director of GEC Marconi, following earlier periods as managing director of GPT, the telecommunications joint venture between GEC and Siemens and of STC Telecommunications.

Sir Peter is a chartered engineer and holds a first class degree in mathematics from Cambridge University.

Sir Peter joined the Board of Tate & Lyle, as Chairman Elect, on 1 February 2009.

About Tate & Lyle

Tate & Lyle is a world-leading renewable food and industrial ingredients company, serving a global market from 48 production facilities mainly throughout the Americas, Europe and South East Asia. Our efficient, large-scale manufacturing plants turn agricultural products, corn and cane sugar into valuable ingredients for our customers. These ingredients add taste, texture, nutrition and increased functionality to products that millions of people around the world use or consume every day.

Tate & Lyle's range of leading branded food ingredients include SPLENDA® Sucralose, PROMITOR™ Dietary Fiber, STA-LITE®, Polydextrose, Tate & Lyle Fairtrade Sugar and Lyle's Golden Syrup. Tate & Lyle also produces branded industrial ingredients including Bio-PDO™, Ethylex® and STA-Lock® paper starches; and staple ingredients such as high fructose corn syrup, sugar, ethanol, citric acid and basic starches. In addition to providing a wide range of ingredients, our expert sales and product applications teams support customers by providing technical advice and proprietary consumer insight studies.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2008, Tate & Lyle employed 6,488 people in its subsidiaries and joint ventures, and sales totalled £3.4 billion.

SPLENDA® is a trademark of McNeil Nutritionals, LLC

Copyright Business Wire 2009

Date   Source Headline
4th Jun 20245:22 pmRNSAnnual Financial Report and Notice of AGM
4th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 202412:00 pmRNSTotal Voting Rights
30th May 202412:15 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSFinal Results
23rd May 20247:00 amRNSSale of remaining interest in Primient JV to KPS
20th May 20241:00 pmRNSDirectorate Change
17th May 20243:30 pmRNSHolding(s) in Company
14th May 20243:30 pmRNSHolding(s) in Company
13th May 202410:00 amRNSHolding(s) in Company
8th May 20243:15 pmRNSHolding(s) in Company
1st May 20242:30 pmRNSTotal Voting Rights
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company
20th Mar 202412:00 pmRNSHolding(s) in Company
19th Mar 20242:00 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
12th Mar 20244:24 pmRNSHolding(s) in Company
12th Mar 20244:22 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSDirectorate Change
4th Mar 20242:00 pmRNSDirector/PDMR Shareholding
4th Mar 20241:45 pmRNSHolding(s) in Company
28th Feb 20242:30 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSTrading Statement
1st Feb 202412:00 pmRNSTotal Voting Rights
11th Jan 20241:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:00 pmRNSBlock listing Interim Review
8th Dec 202311:45 amRNSDirector/PDMR Shareholding
6th Dec 202310:30 amRNSHolding(s) in Company
27th Nov 20234:15 pmRNSHolding(s) in Company
23rd Nov 20232:30 pmRNSHolding(s) in Company
20th Nov 202310:00 amRNSHolding(s) in Company
9th Nov 20237:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.